All terms in MeSH

Label Id Description
Suppressor of Cytokine Signaling Proteins D050826 [A family of structurally related proteins that are induced by CYTOKINES and negatively regulate cytokine-mediated SIGNAL TRANSDUCTION PATHWAYS. SOCS proteins contain a central SH2 DOMAIN and a C-terminal region of homology known as the SOCS box. ]
Syntaxin 1 D050827 [A neuronal cell membrane protein that combines with SNAP-25 and SYNAPTOBREVIN 2 to form a SNARE complex that leads to EXOCYTOSIS. ]
Protein Inhibitors of Activated STAT D050828 [A family of structurally related proteins that are constitutively expressed and that negatively regulate cytokine-mediated SIGNAL TRANSDUCTION PATHWAYS. PIAS proteins inhibit the activity of signal transducers and activators of transcription. ]
Blood Coagulation Disorders, Inherited D025861 [Hemorrhagic and thrombotic disorders that occur as a consequence of inherited abnormalities in blood coagulation. ]
Wld protein, mouse C442580
ETV6-FGFR3 protein, human C442581
Poxviridae Infections D011213 [Virus diseases caused by the POXVIRIDAE. ]
Practice (Psychology) D011214 [Performance of an act one or more times, with a view to its fixation or improvement; any performance of an act or behavior that leads to learning. ]
Practice Management, Dental D011215 [The organization and operation of the business aspects of a dental practice. ]
Practice Management, Medical D011216 [The organization and operation of the business aspects of a physician's practice. ]
20alpha-dimethylamino-2alpha-hydroxyl-3beta-tigloylamino-5alpha-pregnane C549300
Practolol D011217 [A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS. ]
7,8-dihydroxy-3-(3-hydroxy-4-oxo-4H-pyran-2-yl)-2H-chromen-2-one C549301
Prader-Willi Syndrome D011218 [An autosomal dominant disorder caused by deletion of the proximal long arm of the paternal chromosome 15 (15q11-q13) or by inheritance of both of the pair of chromosomes 15 from the mother (UNIPARENTAL DISOMY) which are imprinted (GENETIC IMPRINTING) and hence silenced. Clinical manifestations include MENTAL RETARDATION; MUSCULAR HYPOTONIA; HYPERPHAGIA; OBESITY; short stature; HYPOGONADISM; STRABISMUS; and HYPERSOMNOLENCE. (Menkes, Textbook of Child Neurology, 5th ed, p229) ]
3-hydroxysolavetivone-beta-D-glucoside A C549302
Prajmaline D011219 [A derivative of the rauwolfia alkaloid AJMALINE. It is an anti-arrhythmia agent, but may cause liver damage. ]
3-hydroxysolavetivone-beta-D-glucoside B C549303
Al2(5,8-di-Br-HB)Cl4 C442579
Power Plants D011210 [Units that convert some other form of energy into electrical energy. ]
Electric Power Supplies D011211 [Devices that control the supply of electric current for running electrical equipment. ]